Recent

% | $
Quotes you view appear here for quick access.

DUSA Pharmaceuticals Inc. Message Board

  • ikabro ikabro Nov 11, 2011 9:02 PM Flag

    A must read new article from Nov 10, 2011

    These are the highlights -

    "Henry has a 12-month price target on the stock of $6.50."

    "But he also suspects that Dusa itself could become an acquisition target and fetch a decent premium—a scenario that he believes would validate the turnaround effort he started more than a half-decade ago. “We’re finally getting rid of the old baggage,” Doman says. “We’re not a science project anymore. We’re a real company.”

    http://www.xconomy.com/boston/2011/11/10/dusa-eyes-market-expansion-for-skin-therapy-device/

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • <<<Doman says Dusa is actively looking for acquisition or licensing candidates to fill out its pipeline. “We’re in a good position to bring something in to leverage our sales and marketing capabilities,” he says, adding that the company will most likely stay in field of medical dermatology. But he also suspects that Dusa itself could become an acquisition target and fetch a decent premium—a scenario that he believes would validate the turnaround effort he started more than a half-decade ago. “We’re finally getting rid of the old baggage,” Doman says. “We’re not a science project anymore. We’re a real company.”>>>

      My bet is that DUSA wants to stay independent and will make an "acquisition or licensing" deal in the not too distant future to deter a buyout and boost growth. They've got a fair amount of cash and could use their stock as additional currency. Let's hope they don't repeat the serious Sirius blunder...